NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
4.950
-0.180 (-3.51%)
At close: Apr 22, 2026, 4:00 PM EDT
5.10
+0.15 (3.03%)
After-hours: Apr 22, 2026, 4:39 PM EDT
NTHI Revenue
In the year 2025, NeOnc Technologies Holdings had annual revenue of $39.99K, down -51.82%.
Revenue (ttm)
$39.99K
Revenue Growth
-51.82%
P/S Ratio
3,102.26
Revenue / Employee
$7,998
Employees
5
Market Cap
123.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 39.99K | -43.01K | -51.82% |
| Dec 31, 2024 | 83.00K | 12.54K | 17.79% |
| Dec 31, 2023 | 70.46K | 50.46K | 252.31% |
| Dec 31, 2022 | 20.00K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pyxis Oncology | 13.86M |
| Cibus | 3.64M |
| Kazia Therapeutics | 1.27M |
| Cardiff Oncology | 593.00K |
| InflaRx | 34.44K |
NTHI News
- 21 days ago - NeOnc Provides Business Update and Reports Q4 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - NeOnc Technologies Appoints David Choi as Chief Accounting Officer - GlobeNewsWire
- 5 weeks ago - Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - Newsfile Corp
- 7 weeks ago - NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET - GlobeNewsWire
- 7 weeks ago - NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity - GlobeNewsWire
- 2 months ago - NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management - GlobeNewsWire
- 3 months ago - Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - Newsfile Corp
- 4 months ago - NeOnc Technologies Reports Updated Clinical Results - GlobeNewsWire